微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.2% | -19.46% | 84.62% | 75/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.65% | -16.67% | -77.03% | 80/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.83% | -15.02% | -4.39% | 70/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.96% | -19.13% | 98.66% | 72/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.49% | -34.93% | 91.03% | 75/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.78% | -28.44% | -76.58% | 77/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.33% | -5.13% | -9.02% | 74/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 3.66% | 0.27% | 59.83% | 71/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.29% | 5.05% | 110.09% | 74/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.09% | 3.81% | -68.95% | 74/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 3.51% | 18.18% | -3.84% | 80/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.65% | 11.62% | 67.43% | 82/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.18% | 39.74% | 107.62% | 79/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.05% | 0.96% | -64.65% | 86/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 2.97% | 85.63% | -9.17% | 104/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.27% | -40.22% | 109.62% | 99/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.56% | -24.64% | 50% | 103/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.04% | -20% | -35% | 88/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 1.6% | 125.48% | -70.75% | 117/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 5.47% | 42.08% | 164.25% | 91/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.07% | 200% | 59.23% | 106/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.3% | 622.22% | 120.7% | 86/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -6.28% | -768.09% | -263.12% | 123/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 3.85% | 21.07% | 457.97% | 76/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 0.69% | -61.88% | 283.33% | 100/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.18% | -83.78% | -80.85% | 67/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 0.94% | 109.73% | -70.44% | 105/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 3.18% | -72.49% | 75.69% | 56/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.81% | 524.14% | 63.06% | 64/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.11% | -76.58% | 111.49% | 42/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | -9.66% | -1280% | -183.56% | 107/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 11.56% | 1022.33% | 3886.21% | 17/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 0.29% | 149.15% | -93.88% | 56/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 4.74% | 169.32% | 777.14% | 9/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | -0.7% | -122.65% | -167.96% | 98/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 1.03% | 194.29% | 274.58% | 45/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | -0.59% | -131.55% | -133.52% | 54/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.76% | 540% | -43.04% | 29/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 3.09% | -17.82% | 782.86% | 72/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 0.35% | -94.57% | -81.28% | 38/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 1.87% | -35.74% | 567.5% | 44/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | -0.4% | -102.77% | -110.64% | 32/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |